Targeting Tumor Hypoxia With Hypoxia-Activated Prodrugs

被引：41
|
作者：
Yeh, Jen Jen [1 ]
Kim, William Y. [1 ]
机构：
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 13期
关键词：
PHASE-III TRIAL; PANCREATIC-CANCER; SOLID TUMORS; ANTITUMOR-ACTIVITY; CELL CARCINOMA; ONCOLOGY-GROUP; THERAPY; DOXORUBICIN; BREAST; ADENOCARCINOMA;
D O I：
10.1200/JCO.2014.60.0759
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1505 / 1508
页数：4
相关论文
共 50 条
  • [21] Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs
    O'Connor, Liam J.
    Cazares-Koerner, Cindy
    Saha, Jaideep
    Evans, Charles N. G.
    Stratford, Michael R. L.
    Hammond, Ester M.
    Conway, Stuart J.
    NATURE PROTOCOLS, 2016, 11 (04) : 781 - 794
  • [22] Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
    Francis W Hunter
    Bradly G Wouters
    William R Wilson
    British Journal of Cancer, 2016, 114 : 1071 - 1077
  • [23] Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs
    Liam J O'Connor
    Cindy Cazares-Körner
    Jaideep Saha
    Charles N G Evans
    Michael R L Stratford
    Ester M Hammond
    Stuart J Conway
    Nature Protocols, 2016, 11 : 781 - 794
  • [24] Investigational Hypoxia-Activated Prodrugs: Making Sense of Future Development
    Su, Min-Xia
    Zhang, Le-Le
    Huang, Zhang-Jian
    Shi, Jia-Jie
    Lu, Jin-Jian
    CURRENT DRUG TARGETS, 2019, 20 (06) : 668 - 678
  • [25] Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
    Hunter, Francis W.
    Wouters, Bradly G.
    Wilson, William R.
    BRITISH JOURNAL OF CANCER, 2016, 114 (10) : 1071 - 1077
  • [26] Hypoxia-activated prodrugs of DNA-dependent protein kinase as radiosensitisers
    Hay, M.
    Liew, L.
    Wong, W.
    Dickson, B.
    Cheng, G.
    Hong, C. R.
    Wilson, W.
    Jamieson, S.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S13 - S14
  • [27] Synthesis and biological evaluation of hypoxia-activated prodrugs of SN-38
    Jin, Chen
    Zhang, Qiumeng
    Lu, Wei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 132 : 135 - 141
  • [28] Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors
    Lindsay, Danika
    Garvey, Colleen M.
    Mumenthaler, Shannon M.
    Foo, Jasmine
    PLOS COMPUTATIONAL BIOLOGY, 2016, 12 (08)
  • [29] Design of optimized hypoxia-activated prodrugs using pharmacokinetic/pharmacodynamic modeling
    Foehrenbacher, Annika
    Secomb, Timothy W.
    Wilson, William R.
    Hicks, Kevin O.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [30] Evaluation of heteroaxial cobalt(III) complexes as archetypes for hypoxia-activated prodrugs
    Batista, Renata Crispim
    Gomez, Javier Gomez
    Verani, Claudio Nazari
    Lanznaster, Mauricio
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2017, 22 : S61 - S61
12345